Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue
Mandate

Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue

March 08, 2024 M&A Capital Markets and Public M&A

Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue of Class A and B shares, which provides Annehem with issue proceeds of approximately SEK 300 million before deduction of transaction costs.

The new Class B shares issued in the rights issue are expected to be admitted to trading on Nasdaq Stockholm on or around 13 March 2024. Annehem Fastigheter is a growth-driven property company specializing in commercial, community service and residential properties in the Nordic growth regions of Stockholm, Skåne, Gothenburg and Helsinki. The property portfolio in Annehem Fastigheter consists of 26 investment properties with a value of SEK 4,412.7 million and a lettable area of 202 thousand sqm as of 31 December 2023. The company's Class B shares are listed on Nasdaq Stockholm.

Vinge’s team consisted primarily of Rikard Lindahl, Joel Magnusson, Oskar Nilsson, Michaela Ådén and Lovisa Jonassen.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025